HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-11-18EMA Authorised: Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan (efavirenz;emtricitabine;tenofovir disoproxil maleate) — Mylan Pharmaceuticals Limited
EMA has authorised the fixed-dose combination therapy Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan for the treatment of HIV infections…
-
EMA approval · 2025-11-18EMA Authorised: Viread (tenofovir disoproxil fumarate) — Gilead Sciences Ireland UC
The European Medicines Agency authorised Viread (tenofovir disoproxil fumarate) for chronic hepatitis B and HIV infections; the marketing au…
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Safety, Reactogenicity and Immunogenicity of HB-502 and HB-501 Versus Placebo in People With HIV on Suppressive ART [Phase 1]
Phase 1 clinical trial evaluating safety, reactogenicity, and immunogenicity of HB-502 and HB-501 versus placebo in people with HIV on suppr…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a New Formulation of Cabotegravir Long-Acting Administered Intramuscularly in a 4-month Dosing Interval (Q4M) [Phase 2]
A Phase 2 study evaluating the pharmacokinetics, safety, and tolerability of a new long-acting cabotegravir formulation given every four mon…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus [Phase 2]
Phase 2 trial evaluating autologous cytotoxic T lymphocytes for BK virus and JC virus infections in immunocompromised patients (including AI…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Reduce Tobacco Use in People Living With HIV in Switzerland [NA]
A Basel-based clinical trial in Switzerland aims to reduce tobacco use in people living with HIV. Recruitment is ongoing.
-
EMA approval · 2025-11-17EMA Authorised: Isentress (raltegravir) — Merck Sharp & Dohme B.V.
The EMA has authorised Isentress (raltegravir) for HIV infections; decision dated 12 November 2025.
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Gathering Records to Evaluate Antiretroviral Treatment-South Africa
A clinical trial update describes a study in South Africa that is recruiting to gather records to evaluate antiretroviral treatment for HIV.…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Gathering Records to Evaluate Antiretroviral Treatment-Zambia (GREAT )
The GREAT study is a clinical trial evaluating antiretroviral treatment in Zambia; the study is currently in recruitment.
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Gathering Records to Evaluate Antiretroviral Treatment-Malawi ( GREAT )
A recruiting clinical trial in Malawi led by Boston University is collecting records to evaluate antiretroviral treatment for HIV.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Criminal Justice Coordinated Transitional Care [NA]
A completed clinical trial from the University of Wisconsin–Madison on criminal justice coordinated transitional care; results have been pos…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Bioclinical Evaluation of 2 Biomarkers of Aviremic HIV-1 in CD4+ T Cells of Adults Undergoing Treatment
Clinical trial update evaluating two biomarkers of aviremic HIV-1 in CD4+ T cells of adults undergoing antiretroviral treatment.
-
EMA approval · 2025-11-14EMA Authorised: Juluca (dolutegravir sodium;rilpivirine hydrochloride) — ViiV Healthcare B.V.
EMA authorised Juluca, a fixed-dose combination of dolutegravir and rilpivirine, for HIV infections, with ViiV Healthcare B.V. as the market…
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: Clinical Trial to Evaluate the Safety and Immunogenicity of Synthetic DNAs Encoding NP-GT8 and IL-12, With or Without a TLR-agonist-Adjuvanted HIV Env Trimer 4571 Boost, in Adults Without HIV [Phase 1]
Phase 1 clinical trial assessing safety and immunogenicity of synthetic DNA vaccines encoding NP-GT8 and interleukin-12, with or without a T…
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: POSITIVE OUTCOMES: Improving Quality
Clinical trial update from King's College London reports positive outcomes aimed at improving quality of life for people living with HIV. Th…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1 [Phase 3]
Phase 3 trial comparing an oral weekly islatravir/lenacapavir regimen with standard of care in virologically suppressed people with HIV-1; t…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Scale-up of an Evidence-based Adolescent Transition Package to Support Transitional Care Among Youth Living With HIV [NA]
A clinical trial update describing the scale-up of an evidence-based adolescent transition package to support transitional care for youth li…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries [NA]
Clinical trial evaluating optimization of cervical cancer screening among women living with HIV in Latin America; the study is active but no…
-
CLINICAL_TRIALS trial_result · 2025-11-13Clinical Trial Update: Pharmacokinetic and Safety Study of a 90 Day Intravaginal Ring Containing Tenofovir [Phase 1]
Phase 1 pharmacokinetic and safety study of a 90-day intravaginal ring containing tenofovir; results have been completed and posted.
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1 [Phase 3]
A Phase 3 clinical trial update comparing an oral weekly islatravir/lenacapavir regimen versus Bictegravir/Emtricitabine/Tenofovir alafenami…
-
CLINICAL_TRIALS trial_result · 2025-11-13Clinical Trial Update: Pain Inflammation and Cannabis in HIV [NA]
This clinical trial update reports a completed study evaluating cannabis for pain and inflammation in HIV infection. Results were posted on …
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum
A clinical trial update reporting pharmacokinetic properties of antiretroviral and anti-tuberculosis drugs during pregnancy and postpartum.
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: An Extension Protocol for Subjects Who Successfully Completed PRO140_CD02 or PRO140_CD02_Open Label Study [Phase 2, Phase 3]
This clinical trial update describes an extension protocol for HIV subjects who completed the PRO140_CD02 studies. The study (Phase 2/3) is …
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Intervention to Reduce Implicit Bias in Pharmacies [NA]
A Massachusetts General Hospital trial seeks to test an intervention to reduce implicit bias among pharmacists, with relevance to HIV preven…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma [Phase 1]
A Phase 1 trial evaluating gene therapy in combination with chemotherapy for AIDS-related non-Hodgkin lymphoma (including AIDS-related Burki…